Ocugen to present gene therapy platform at investor and industry conferences
OCGN•Ocugen CEO Shankar Musunuri will discuss the company's modifier gene therapy platform at two conferences in November 2026.
1. Conference appearances
Musunuri is scheduled to present at the Stifel 2026 Healthcare Conference in New York on Nov. 12, from 10:00 to 10:30 a.m. ET. He will also join a Cell & Gene Leaders Live 2026 panel at London's Shard on Nov. 15, from 3:15 to 4:00 p.m. GMT.
